Clean Science and Technology Limited (CLEAN.NS)
Pune, IN
Clean Science and Technology Limited, established in Pune, India, in 2003, is an enterprise focused on the entire lifecycle of specialized chemical products, from their research and development to manufacturing and international distribution. Its extensive product catalog includes compounds such as anisole, mono methyl ether of hydroquinone, guaiacol, 4-methoxy acetophenone, butylated hydroxy anisole, veratrole, L-ascorbyl palmitate, N,N'-dicyclohexylcarbodiimide, tertiary butyl hydroquinone, para benzoquinone, 2,5-di-tertiary butyl hydroquinone, and para di-methoxy benzene (1,4-DMB). The company's diverse offerings cater to both consumer and industrial sectors.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -6.23% | -13.24% | +1.27% | +2.93% | -17.98% | -12.45% | -40.36% | -49.78% | -51.62% | -51.62% | -51.62% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 7 | 0 |
| Hold | 4 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 2 | +1 |
-
Revenue growth Chemicals - Specialty: +4.7%-1.0% Q1'26: -5.5% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-13.2% Q1'26: -21.4% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+20.5% Q1'26: +23.7% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+29.0% ★ Q1'26: +30.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+17.0% ★ Q1'26: +18.6% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.01× ★ Q1'26: 0.01× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 12 Rev. Ana. 11 EPS Ana. |
Mar 2027 12 Rev. Ana. 12 EPS Ana. |
Mar 2028 13 Rev. Ana. 13 EPS Ana. |
Mar 2029 5 Rev. Ana. 4 EPS Ana. |
Mar 2030 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
6.85B
est: 6.79B (+0.9%)
|
9.36B
est: 9.37B (-0.2%)
|
7.91B
est: 8.27B (-4.3%)
|
9.67B
est: 9.76B (-1.0%)
|
9.53B
9.33B – 9.93B
-2.3% YoY
|
11.69B
11.07B – 12.16B
+22.6% YoY
|
15.09B
13.57B – 17.16B
+29.1% YoY
|
18.41B
16.94B – 20.16B
+22.0% YoY
|
20.78B
19.13B – 22.75B
+12.9% YoY
|
| EBITDA |
3.00B
est: 2.97B (+0.8%)
|
4.02B
est: 4.11B (-2.2%)
|
3.31B
est: 3.40B (-2.7%)
|
3.87B
est: 4.01B (-3.7%)
|
3.92B
3.84B – 4.08B
-2.3% YoY
|
4.81B
4.56B – 5.00B
+22.6% YoY
|
6.21B
5.58B – 7.06B
+29.1% YoY
|
7.57B
6.97B – 8.29B
+22.0% YoY
|
8.55B
7.87B – 9.36B
+12.9% YoY
|
| EBIT |
2.75B
est: 2.65B (+3.6%)
|
3.66B
est: 3.67B (-0.2%)
|
2.86B
est: 2.94B (-2.5%)
|
3.19B
est: 3.46B (-8.0%)
|
3.38B
3.31B – 3.52B
-2.3% YoY
|
4.15B
3.93B – 4.31B
+22.6% YoY
|
5.35B
4.82B – 6.09B
+29.1% YoY
|
6.53B
6.01B – 7.15B
+22.0% YoY
|
7.37B
6.79B – 8.07B
+12.9% YoY
|
| Net Income |
2.28B
est: 2.36B (-3.2%)
|
2.95B
est: 2.91B (+1.4%)
|
2.44B
est: 2.51B (-2.8%)
|
2.64B
est: 2.69B (-1.5%)
|
2.30B
2.27B – 2.59B
-14.5% YoY
|
2.79B
2.70B – 3.30B
+21.6% YoY
|
3.58B
3.27B – 4.44B
+28.3% YoY
|
4.43B
4.14B – 4.72B
+23.6% YoY
|
5.10B
4.57B – 5.73B
+15.3% YoY
|
| SGA |
347.80M
est: 413.01M (-15.8%)
|
454.65M
est: 570.59M (-20.3%)
|
486.64M
est: 702.55M (-30.7%)
|
564.45M
est: 828.71M (-31.9%)
|
809.56M
791.91M – 842.94M
-2.3% YoY
|
992.67M
940.24M – 1.03B
+22.6% YoY
|
1.28B
1.15B – 1.46B
+29.1% YoY
|
1.56B
1.44B – 1.71B
+22.0% YoY
|
1.76B
1.62B – 1.93B
+12.9% YoY
|
| EPS |
21.51
est: 22.20 (-3.1%)
|
27.79
est: 28.15 (-1.3%)
|
22.97
est: 23.63 (-2.8%)
|
24.88
est: 25.96 (-4.2%)
|
22.73
21.36 – 24.32
-12.5% YoY
|
28.05
25.38 – 31.06
+23.4% YoY
|
35.36
30.75 – 41.71
+26.1% YoY
|
42.50
38.96 – 44.36
+20.2% YoY
|
48.00
43.03 – 53.92
+12.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.03% | 213.2K | 0.65% |
| 2 | WisdomTree India Earnings Fund EPI | 0.02% | 448.1K | 0.84% |
| 3 | WisdomTree Emerging Markets SmallCap Dividend UCITS ETF DGSD.L | 0.01% | 4.9K | 0.54% |
| 4 | State Street SPDR Portfolio MSCI Global Stock Market ETF SPGM | 0.01% | 91.9K | 0.09% |
| 5 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 91.3K | 0.29% |
| 6 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 79.4K | 0.39% |
| 7 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 19.8K | 0.28% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ashok Ramnarayan Boob | Whole Time Director & Executive Vice Chairman | 95M | male |
| KrishnaKumar Ramnarayan Boob | Promotor & Whole-time Director | 57M | male |
| Krishnakumar Satyanarain Saboo | President of Operations | — | male |
| Mubina Baber | Head of Human Resource | — | female |
| Pratik Abhaykumar Bora | Vice President of Corporate Finance | — | male |
| Ruchita Kumar Vij | Company Secretary & Compliance Officer | — | female |
| Sanjay Wamanrao Parnerkar | Chief Financial Officer | — | male |
| Siddharth Ashok Sikchi | Managing Director | — | male |
| Vijay Jadhav | Head of Safety | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CLEAN.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
